FDA approves Moderna’s mRNA flu vaccine after initially refusing to review it After refusing to even review it, the FDA has approved Moderna’s mRNA seasonal flu vaccine. RelatedThe new COVID-19 vaccines are here for the fallSeptember 14, 2023In "Technology"Japan pledges $2 billion in funding for pandemic vaccine research initiativeSeptember 24, 2022In "Technology"The most common oral decongestant in the US does not work, FDA findsSeptember 12, 2023In "Technology"